Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)

Obstet Gynecol. 2020 Nov;136(5):1025-1029. doi: 10.1097/AOG.0000000000004050.

Abstract

Background: There are limited data regarding treatment options for pregnant women with severe coronavirus disease 2019 (COVID-19).

Case: A 35-year-old primigravid patient at 22 weeks of gestation presented with 7 days of fever, cough, anosmia, and dyspnea. Nasopharyngeal swab was positive for the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and a chest X-ray demonstrated bilateral patchy infiltrates. Laboratory evaluation was notable for marked elevation of interleukin-6 and C-reactive protein concentrations. On hospital day 3, owing to increased dyspnea and oxygen requirement, the patient was treated with tocilizumab followed by 5 days of remdesivir. She responded well, recovered to room air, and was discharged home after a 9-day hospitalization.

Conclusion: Tocilizumab and remdesivir may be effective for treatment of severe COVID-19 in pregnancy, but additional data are needed to guide risk-benefit considerations.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Monophosphate / administration & dosage
  • Adenosine Monophosphate / analogs & derivatives*
  • Adult
  • Alanine / administration & dosage
  • Alanine / analogs & derivatives*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antiviral Agents / administration & dosage
  • Betacoronavirus / isolation & purification
  • C-Reactive Protein / analysis
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections* / blood
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / physiopathology
  • Female
  • Humans
  • Interleukin-6 / blood
  • Lung / diagnostic imaging*
  • Oximetry / methods
  • Pandemics*
  • Pneumonia, Viral* / blood
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / etiology
  • Pneumonia, Viral* / physiopathology
  • Pregnancy
  • Pregnancy Complications, Infectious* / blood
  • Pregnancy Complications, Infectious* / diagnosis
  • Pregnancy Complications, Infectious* / drug therapy
  • Radiography, Thoracic / methods
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antiviral Agents
  • Interleukin-6
  • remdesivir
  • Adenosine Monophosphate
  • C-Reactive Protein
  • tocilizumab
  • Alanine